Your browser doesn't support javascript.
loading
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial.
Bamias, A; Gibbs, E; Khoon Lee, C; Davies, L; Dimopoulos, M; Zagouri, F; Veillard, A-S; Kosse, J; Santaballa, A; Mirza, M R; Tabaro, G; Vergote, I; Bloemendal, H; Lykka, M; Floquet, A; Gebski, V; Pujade-Lauraine, E.
Afiliación
  • Bamias A; HECOG and Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Gibbs E; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Khoon Lee C; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Davies L; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Dimopoulos M; HECOG and Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Zagouri F; HECOG and Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Veillard AS; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Kosse J; AGO and Department of Gynaecology, Sana Klinikum Offenbach, Offenbach, Germany.
  • Santaballa A; GEICO and Medical Oncology Department, University Hospital and Polytechnic, Valencia, Spain.
  • Mirza MR; NSGO and Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
  • Tabaro G; MITO and USCC/Dir. Scientifica, Centro di Riferimento Oncologico, CRO-IRCCS, Aviano, Italy.
  • Vergote I; BGOG and Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, University Hospital Leuven, Leuven, Belgium.
  • Bloemendal H; DGOG and Department of Internal Medicine/Oncology, Meander Medical Center, Amersfoort, The Netherlands.
  • Lykka M; HECOG and Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Floquet A; GINECO and Medical Oncology and Genetics Department, Institut Bergonié, Bordeaux.
  • Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
  • Pujade-Lauraine E; GINECO and Paris Descartes University, AP-HP Central Paris University Hospitals, Paris, France.
Ann Oncol ; 28(8): 1842-1848, 2017 Aug 01.
Article en En | MEDLINE | ID: mdl-28481967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Grecia